Optellum News | Lung Cancer AI Company Updates | Optellum

20 October 2026 / Partnerships

Optellum and RapidAI Bring AI-Supported Lung Nodule Management to the Rapid Enterprise™ Platform

Optellum’s Virtual Nodule Clinic with LCP AI is now integrated with RapidAI’s Rapid Enterprise™ Platform, enabling health systems to deploy through a single IT deployment.

08 September 2026 / Awards

Optellum Wins the Clinical Excellence & Evidence Award at MedTech World Asia Awards 2026

Optellum wins the Clinical Excellence & Evidence Award at MedTech World Asia 2026, highlighting our commitment to innovation in lung cancer diagnosis and treatment.

24 August 2026 / Awards

SimonMed Launches Worlds First Seamlessly Integrated AI Lung Nodule Risk Assessment Workflow

SimonMed partners with Optellum to integrate LCP AI into its imaging workflow, bringing AI-supported malignancy risk assessment to eligible incidental lung nodules.

13 August 2026 / News & Press

Coreline Soft and Optellum announce intent to collaborate to advance AI across the lung cancer pathway

Optellum and Coreline Soft are collaborating to enhance AI-enabled lung cancer care, integrating detection and management to improve patient outcomes.

15 June 2026 / Partnerships

Optellum Awarded NIHR Funding for Multi-Site NHS Pilot Study for Accelerated Lung Cancer Diagnosis

Optellum announced it has been awarded funding for a competitive programme, Invention for Innovation (i4i), focused on transformative and disruptive innovations to reduce waiting lists and waiting tim

10 June 2026 / Partnerships

Tanner Health and Healthliant Ventures Partner with Optellum to Bring AI for Lung Health to the Region

Tanner Health and Healthliant Ventures announce the launch of Optellum’s Virtual Nodule Clinic® (VNC), an artificial intelligence (AI) platform designed to assist care teams in identifying, risk asses

04 June 2026 / News & Press

Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing

03 June 2026 / Partnerships

Massive Bio and Optellum Collaborate to Accelerate Clinical Trial Access for Early-Stage Non-Small Cell Lung Cancer Patients

Massive Bio and Optellum today announced a collaboration to bridge early lung cancer detection with clinical trial access for patients with non-small cell lung cancer (NSCLC).

24 March 2026 / News & Press

Optellum AI Shown to be Highly Cost-Effective in First US Lifetime Payer Study of Lung Nodule Risk Stratification

First lifetime payer-perspective economic analysis of AI-assisted risk stratification for indeterminate pulmonary nodules (IPN).

26 February 2026 / News & Press

Optellum Secures TGA Approval to Expand AI-Enabled Lung Nodule Solution to Australia

Optellum is thrilled to announce that it has received Therapeutic Goods Administration (TGA) class IIb approval in Australia for Virtual Nodule Clinic (VNC) platform to support early lung cancer diagn

29 January 2026 / News & Press

NHS launches a single end-to-end lung cancer diagnostic pathway initiative with Optellum

Optellum is pleased to announce its selection in a landmark NHS initiative...

08 January 2026 / News & Press

Optellum Welcomes Two New Strategic Investors to Accelerate Precision Lung Care

Optellum announced the closure of its Series B funding round. The round included new investment from Woori Venture Partners, the venture arm of Woori Financial Group, and Healthliant Ventures, the ven

17 December 2025 / News & Press

Optellum Announces New Clinical Evidence Demonstrating the Real-World Impact of AI on Lung Cancer Care

Optellum announced new clinical evidence demonstrating the impact of its Virtual Nodule Clinic (VNC) with Lung Cancer Prediction (LCP) AI...

26 August 2025 / News & Press

Optellum Debuts World's First Thorax CT Foundation Model Built for Real-World Precision Lung Care

Optellum announced the world’s first thorax CT foundation model built for precision lung care in real-world settings – an ambitious initiative aiming to revolutionize the early detection and managemen

30 July 2025 / Events

Optellum is proud to announce our sponsorship of the Society for Advanced Bronchoscopy

20 June 2025 / Research & Publications

Call for participants: Lung cancer detection reader study

22 January 2025 / Customer stories

Transforming lung cancer diagnosis: Optellum's AI-powered Virtual Nodule Clinic at Atrium Health

We're excited to see how technology is transforming patient care across North Carolina, as highlighted in this recent article featuring Optellum Virtual Nodule Clinic.

09 December 2024 / Customer stories

UConn Health News Features

We are thrilled to share a recent article and TV news segment from UConn Today highlighting the significant strides UConn Health has made in early lung cancer detection.

12 November 2024 / News & Press

Optellum's Solutions Now Available on G-Cloud 14

15 October 2024 / News & Press

PRESS RELEASE: Transforming Lung Cancer Care: Optellum Awarded Grant to Advance AI Imaging Technology.

09 August 2024 / Clinical & Regulatory

PRESS RELEASE: Optellum achieves ISO 27001:2022 certification

01 August 2024 / Events

Remembering our mission this World Lung Cancer Day 2024

22 July 2024 / Customer stories

New whitepaper with Georgia Cancer Center highlights value of Lung Cancer Prediction AI

30 May 2024 / Events

Optellum showcases AI for precision lung cancer treatment at ASCO 2024

Optellum and RapidAI Bring AI-Supported Lung Nodule Management to the Rapid Enterprise™ Platform

Optellum and RapidAI Bring AI-Supported Lung Nodule Management to the Rapid Enterprise™ Platform

Optellum Wins the Clinical Excellence & Evidence Award at MedTech World Asia Awards 2026

SimonMed Launches Worlds First Seamlessly Integrated AI Lung Nodule Risk Assessment Workflow

Coreline Soft and Optellum announce intent to collaborate to advance AI across the lung cancer pathway

Optellum Awarded NIHR Funding for Multi-Site NHS Pilot Study for Accelerated Lung Cancer Diagnosis

Tanner Health and Healthliant Ventures Partner with Optellum to Bring AI for Lung Health to the Region

Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing

Massive Bio and Optellum Collaborate to Accelerate Clinical Trial Access for Early-Stage Non-Small Cell Lung Cancer Patients

Optellum AI Shown to be Highly Cost-Effective in First US Lifetime Payer Study of Lung Nodule Risk Stratification

Optellum Secures TGA Approval to Expand AI-Enabled Lung Nodule Solution to Australia

NHS launches a single end-to-end lung cancer diagnostic pathway initiative with Optellum

Optellum Welcomes Two New Strategic Investors to Accelerate Precision Lung Care

Optellum Announces New Clinical Evidence Demonstrating the Real-World Impact of AI on Lung Cancer Care

Optellum Debuts World's First Thorax CT Foundation Model Built for Real-World Precision Lung Care

Optellum is proud to announce our sponsorship of the Society for Advanced Bronchoscopy

Call for participants: Lung cancer detection reader study

Transforming lung cancer diagnosis: Optellum's AI-powered Virtual Nodule Clinic at Atrium Health

UConn Health News Features

Optellum's Solutions Now Available on G-Cloud 14

PRESS RELEASE: Transforming Lung Cancer Care: Optellum Awarded Grant to Advance AI Imaging Technology.

PRESS RELEASE: Optellum achieves ISO 27001:2022 certification

Remembering our mission this World Lung Cancer Day 2024

New whitepaper with Georgia Cancer Center highlights value of Lung Cancer Prediction AI

Optellum showcases AI for precision lung cancer treatment at ASCO 2024

Redefining early intervention of lung disease starting with one of the deadliest, lung cancer